Skip to main content
. Author manuscript; available in PMC: 2014 Aug 1.
Published in final edited form as: Antiviral Res. 2013 Dec 19;102:87–94. doi: 10.1016/j.antiviral.2013.12.004

Fig. 1.

Fig. 1

Study timelines and CVL sample collection points (black arrows). Participants used an ACV IVR from Day 0 (24 h after last dose of oral VACV) to Day 7 (Group A, n = 3) and Day 14 (Group B, n = 3). CVL was collected for microbial DNA isolation on: Group A, Days 0 (pre-dose), 1, 3, and 7 (upon IVR removal); Group B, Days 0 (pre-dose), 1, 3, 7, 10, and 14 (upon IVR removal).